R&D
Boost Beyond Boundaries
- Publications
- Posters
| No. | Pipeline | Journal | Year | Title | ||
|---|---|---|---|---|---|---|
| 8 | AST-035 | The Korean Neurosurgical Society | 2025 | Novel Thalidomide Derivative AST-035A shows Enhanced Anti-Tumor Efficacy against Glioblastoma as a Molecular Glue |
||
| 7 | AST-001 | Frontiers in Pharmacology | 2024 | Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder |
||
| 6 | AST-001 | PCN | 2024 | AST-001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial |
||
| 5 | AST-001 | Biomedicines | 2023 | AST-001 Improves Social Deficits and Restores Dopamine Neuron Activity in a Mouse Model of Autism |
||
| 4 | AST-001 | Appl Microsc | 2023 | Changes of lysosome by L-Serine in rotenone-treated hippocampal neurons |
||
| 3 | AST-001 | Int J Mol Sci. | 2022 | Restoration of Cathepsin D Level via L-Serine Attenuates PPA-Induced Lysosomal Dysfunction in Neuronal Cells |
||
| 2 | AST-001 | Front Phamarcol. | 2022 | Population Pharmacokinetic Model of AST-001, L-Isomer of Serine, Combining Endogenous Production and Exogenous Administration in Healthy Subjects |
||
| 1 | AST-001 | Free Radic Biol Med. | 2019 | L-Serine protects mouse hippocampal neuronal HT22 cells against oxidative stress-mediated mitochondrial damage and apoptotic cell death |